Skip to content

Methadone included, tenofovir excluded, from new WHO essential drugs list

Pegylated interferon superior to lamivudine for first line hepatitis B treatment

Pfizer discontinues capravirine development

3 million on treatment target unlikely to be met by end of 2005, says WHO

Proof-of-concept study shows benefits of Kaletra / efavirenz combination

Efavirenz reduces blood statin concentrations

Bristol Myers Squibb to cut price of two HIV drugs for children

Brazil warns of generic Kaletra unless Abbott halves price within 10 days

Tipranavir receives US marketing approval